{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:50:44Z","timestamp":1757627444226,"version":"3.44.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"crossref","award":["23K08657"],"award-info":[{"award-number":["23K08657"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sapporo Medical University Grants for Programs promoting Academic advancements"},{"DOI":"10.13039\/100007591","name":"Akiyama Life Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007591","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-025-01263-2","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T23:31:59Z","timestamp":1753140719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SMU-pRMS: a novel cell line of pleomorphic rhabdomyosarcoma"],"prefix":"10.1007","volume":"38","author":[{"given":"Naoya","family":"Nakahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2512-2795","authenticated-orcid":false,"given":"Makoto","family":"Emori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Murahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Murase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohide","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousuke","family":"Iba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohichi","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Osanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Teramoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"1263_CR1","unstructured":"Montgomery EA DS. Pleomorphic rhabdomyosarcoma. WHO Classification of Tumours of Soft Tissue and Bone. Lyon: IARC Press, 2020; 209\u201310."},{"key":"1263_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/cncr.10669","volume":"95","author":"DJ Little","year":"2002","unstructured":"Little DJ, Ballo MT, Zagars GK, et al. Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer. 2002;95:377\u201388.","journal-title":"Cancer"},{"key":"1263_CR3","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s13577-023-00944-0","volume":"36","author":"M Emori","year":"2023","unstructured":"Emori M, Nakahashi N, Takasawa A, et al. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, SMU-DDCS, harboring an IDH1 mutation. Hum Cell. 2023;36:2195\u2013203.","journal-title":"Hum Cell"},{"key":"1263_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fonc.2013.00183","volume":"3","author":"AR Hinson","year":"2013","unstructured":"Hinson AR, Jones R, Crose LE, Belyea BC, Barr FG, Linardic CM. Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls. Front Oncol. 2013;3:183.","journal-title":"Front Oncol"},{"key":"1263_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.tranon.2019.10.005","volume":"13","author":"K Igarashi","year":"2020","unstructured":"Igarashi K, Kawaguchi K, Zhao M, et al. Exquisite tumor targeting by Salmonella A1-R in combination with caffeine and valproic acid regresses an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft mouse model. Transl Oncol. 2020;13:393\u2013400.","journal-title":"Transl Oncol"},{"key":"1263_CR6","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1038\/s41598-025-87027-2","volume":"15","author":"S Stickler","year":"2025","unstructured":"Stickler S, Lang C, Rieche M, et al. Characterization of a pleomorphic rhabdomyosarcoma cell line. Sci Rep. 2025;15:2893.","journal-title":"Sci Rep"},{"key":"1263_CR7","first-page":"119","volume":"17","author":"H Sonobe","year":"2000","unstructured":"Sonobe H, Takeuchi T, Taguchi T, Shimizu K, Furihata M, Ohtsuki Y. A new human pleomorphic rhabdomyosarcoma cell-line, HS-RMS-1, exhibiting MyoD1 and myogenin. Int J Oncol. 2000;17:119\u201325.","journal-title":"Int J Oncol"},{"key":"1263_CR8","first-page":"119","volume":"38","author":"RTM Oyama","year":"2019","unstructured":"Oyama RTM, Kito F, Sakumoto M, Takai Y, Shiozawa K, Qiao Z, Toki S, Tanzawa Y, Yoshida A, Kawai A, Kondo T. Establishment and characterization of patient-derived pleomorphic rhabdomyosarcoma models. Tiss Cult Res Commun. 2019;38:119\u201325.","journal-title":"Tiss Cult Res Commun."},{"key":"1263_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1470-2045(14)70063-4","volume":"15","author":"I Judson","year":"2014","unstructured":"Judson I, Verweij J, Gelderblom H, et al. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol. 2014;15:415\u201323.","journal-title":"Lancet Oncol"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01263-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-025-01263-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01263-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T03:34:51Z","timestamp":1757475291000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-025-01263-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":9,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["1263"],"URL":"https:\/\/doi.org\/10.1007\/s13577-025-01263-2","relation":{},"ISSN":["1749-0774"],"issn-type":[{"type":"electronic","value":"1749-0774"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they either have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board of Sapporo Medical University (reference number 282\u2013156). Written informed consent was obtained from the patient in accordance with the guidelines of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"132"}}